Last updated on November 2019

Evaluation of the Nonmotor Symptomatology of Parkinsonian Patients Treated With Two Strategies Related to Apomorphine Pump Therapy in French Hospitals

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Parkinson's Disease
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Adults aged = or > 18 years,
  • Idiopathic PD (According to British Brain Bank Criteria) without any other known or suspected cause of symptoms,
  • Indicated for apomorphine pump therapy and according to the centers' practice, treatment with apomorphine pump association with dopamine agonists or apomorphine pump therapy alone
  • Presence of fluctuations for > 3 years,
  • Patients covered with social insurance.
  • Written informed consent

Exclusion Criteria:

  • Neurological (other than Parkinson's disease) or severe psychiatric history (depression, schizophrenia, addiction, bipolar disorder, anxiety and depressive disorders);
  • Severe neurocognitive disorders (DSM-V)
  • History of use of apomorphine pump treatment or deep brain stimulation or lesional surgery for PD or intrajejunal L-Dopa;
  • History or current drug or alcohol abuse or dependencies;
  • History of impulse control disorders;
  • Adults legally protected (under judicial protection, guardianship or supervision), persons deprived of their liberty;
  • Inability to understand the information given on the study, to express informed consent.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.